This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (1)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Psychiatry  • Depression  • Adverse Effects  • Alert me on articles by topic

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: While the TADS trial provides valuable data about a significant problem, we differ from the authors in their conclusion that treatment with fluoxetine should be made widely available, and that CBT in combination with fluoxetine should be "readily available as part of comprehensive treatment for depressed adolescents."¹ Because 2 of 3 outcome measures (Clinical Global Impressions [CGI] and Reynolds Adolescent Depression Scale [RADS]) show no significant difference between fluoxetine treatment alone and fluoxetine in combination with CBT, we do not see this study showing an advantage for the addition of CBT in all adolescents with MDD.

The Suicidal Ideation Questionnaire-Junior High School Version showed significantly more improvement with fluoxetine in combination with CBT compared with fluoxetine alone. Although this difference may not apply to attempted or completed suicides, it does lend support for the use of fluoxetine in combination with CBT for adolescents with MDD and suicidal . . . [Full Text of this Article]

Arthur Rifkin, MD
Department of Psychiatry
Zucker-Hillside Hospital
North Shore-Long Island Jewish Health System
New Hyde Park, NY

William Rifkin, MD
william.rifkin@yale.edu
Department of Medicine
Yale University School of Medicine
New Haven, Conn

RELATED ARTICLES

Adolescents With Depression
David Antonuccio and David Burns
JAMA. 2004;292(21):2577.
EXTRACT | FULL TEXT  

Adolescents With Depression
Bernard J. Carroll
JAMA. 2004;292(21):2578.
EXTRACT | FULL TEXT  

Adolescents With Depression
Jeffrey A. Bridge and David A. Brent
JAMA. 2004;292(21):2578.
EXTRACT | FULL TEXT  

Adolescents With Depression—Reply
John S. March
JAMA. 2004;292(21):2578-2579.
EXTRACT | FULL TEXT  

Fluoxetine, Cognitive-Behavioral Therapy, and Their Combination for Adolescents With Depression: Treatment for Adolescents With Depression Study (TADS) Randomized Controlled Trial
Treatment for Adolescents With Depression Study Team
JAMA. 2004;292(7):807-820.
ABSTRACT | FULL TEXT